Whole-genome sequencing: a step closer to personalized medicine
- PMID: 21505140
- DOI: 10.1001/jama.2011.484
Whole-genome sequencing: a step closer to personalized medicine
Comment on
-
Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.JAMA. 2011 Apr 20;305(15):1568-76. doi: 10.1001/jama.2011.473. JAMA. 2011. PMID: 21505135 Free PMC article.
-
Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.JAMA. 2011 Apr 20;305(15):1577-84. doi: 10.1001/jama.2011.497. JAMA. 2011. PMID: 21505136 Free PMC article.
Similar articles
-
Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.JAMA Oncol. 2015 Oct;1(7):879-80. doi: 10.1001/jamaoncol.2015.1540. JAMA Oncol. 2015. PMID: 26181886 No abstract available.
-
Genomics of AML: clinical applications of next-generation sequencing.Hematology Am Soc Hematol Educ Program. 2011;2011:30-5. doi: 10.1182/asheducation-2011.1.30. Hematology Am Soc Hematol Educ Program. 2011. PMID: 22160009 Review.
-
Genomics in medicine: maturation, but not maturity.JAMA. 2013 Apr 10;309(14):1522-4. doi: 10.1001/jama.2013.3818. JAMA. 2013. PMID: 23571591 No abstract available.
-
Toward individualized treatment in urologic oncology.Urol Oncol. 2015 Apr;33(4):170. doi: 10.1016/j.urolonc.2014.10.005. Epub 2015 Feb 4. Urol Oncol. 2015. PMID: 25661236 Review. No abstract available.
-
The road to precision oncology.Nat Genet. 2017 Feb 24;49(3):320-321. doi: 10.1038/ng.3796. Nat Genet. 2017. PMID: 28232728
Cited by
-
Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.Expert Rev Anticancer Ther. 2012 Oct;12(10):1289-97. doi: 10.1586/era.12.116. Expert Rev Anticancer Ther. 2012. PMID: 23176617 Free PMC article.
-
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.PLoS Biol. 2013 Nov;11(11):e1001699. doi: 10.1371/journal.pbio.1001699. Epub 2013 Nov 5. PLoS Biol. 2013. PMID: 24223516 Free PMC article.
-
The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.Genet Med. 2017 Jun;19(6):683-690. doi: 10.1038/gim.2016.174. Epub 2016 Dec 1. Genet Med. 2017. PMID: 27906201
-
Integrative network modeling approaches to personalized cancer medicine.Per Med. 2015 Jun 1;12(3):245-257. doi: 10.2217/pme.14.87. Per Med. 2015. PMID: 27019658 Free PMC article.
-
A genetic counselor's guide to using next-generation sequencing in clinical practice.J Genet Couns. 2014 Aug;23(4):455-62. doi: 10.1007/s10897-013-9662-7. Epub 2013 Oct 24. J Genet Couns. 2014. PMID: 24151055
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources